Growth hormone bioactivity and immunoactivity in tall children

被引:11
作者
Bozzola, M
Radetti, G
Buzi, F
Tonini, G
Moretta, A
Autelli, M
Aglialoro, A
Rondini, G
Barreca, A
机构
[1] Univ Pavia, Dipartimento Sci Pediat, IRCCS, Policlin San Matteo, I-27100 Pavia, Italy
[2] Div Pediat, Bolzano, Italy
[3] Univ Brescia, Pediat Clin, I-25121 Brescia, Italy
[4] Univ Trieste, Ctr Endocrinol Pediat Auxol, Ist Infanzia, IRCCS Burlo Garofolo, I-34127 Trieste, Italy
[5] IRCCS, Serv Anal Chim Clin, Policlin San Matteo, Pavia, Italy
[6] Univ Genoa, Dipartimento Endocrinol & Metab, I-16126 Genoa, Italy
关键词
tall stature; growth hormone; growth hormone bioactivity; growth hormone binding protein; insulin-like growth factor-I;
D O I
10.1007/BF03343606
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In subjects with constitutional tall stature, both low and high GH response to stimulation tests have been observed when measured by commercial kits. To investigate the reason for these conflicting results, we evaluated growth hormone (GH) secretion using different assays as well as GH-binding protein and insulinlike growth factor-I (IGF-I) concentrations in tall children. Serum samples were collected from 22 prepubertal constitutionally tall children, aged 2.87-13.25 years, during two pharmacological tests to evaluate serum GH levels measured by both immunofluorometric assay (IFMA) and the Nb2 celt bioassay, Serum IGF-I values were evaluated by RIA. Circulating low affinity (LA) and high affinity (HA) CH-binding proteins (GHBPs) were evaluated by FPLC gel filtration. Considering the highest serum CH levels as measured by IFMA, the 22 tall subjects were divided into two groups: group A including 16 children with blunted serum GH peak levels (5.78+/-0.68 ng/ml) and group B including 6 subjects with normal serum GH peak values (15.73+/-1.56 ng/ml). No differences were observed in serum GH peak levels as measured by the Nb2 cell bioassay between group A (14.77+/-1.54 ng/ml) and group B (16.03+/-1.96 ng/ml), and between both groups and 11 age-and sex-matched controls (12.25+/-1.19 ng/ml). In group A, the Nb2 celt bioassay/IFMA ratio of serum GH peak levels (0.29+/-0.08) was significantly higher (p<0.05) than in group B (0.07+/-0.01). No differences were found in serum LA-GHBP and HA-GHBP as well as in IGF-I concentrations between the 16 patients of group A and the 6 of group B. Likewise, no difference in auxological parameters was found between the two groups. The biological activity of GH evaluated using the Nb2 cell bioassay is similar in tall children with a low GH response as measured by IFMA in comparison with those with a normal CH response, and is in agreement with both the auxological data and serum IGF-I concentrations. (C) 1999, Editrice Kurtis.
引用
收藏
页码:541 / 546
页数:6
相关论文
共 35 条
[1]  
ALBERTSSONWIKLAND K, 1993, CLIN CHEM, V39, P1620
[2]   RELATIONSHIP OF PLASMA GROWTH HORMONE-RELEASING HORMONE LEVELS TO PUBERTAL CHANGES [J].
ARGENTE, J ;
EVAINBRION, D ;
MUNOZVILLA, A ;
GARNIER, P ;
HERNANDEZ, M ;
DONNADIEU, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (03) :680-682
[3]  
BAUMANN G, 1990, ACTA PAEDIATR SCAND, P72
[4]   GROWTH-HORMONE HETEROGENEITY - GENES, ISOHORMONES, VARIANTS, AND BINDING-PROTEINS [J].
BAUMANN, G .
ENDOCRINE REVIEWS, 1991, 12 (04) :424-449
[5]   MOLECULAR-FORMS OF HUMAN GROWTH-HORMONE SECRETED INVIVO - NONSPECIFICITY OF SECRETORY STIMULI [J].
BAUMANN, G ;
STOLAR, MW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (04) :789-790
[7]   TABLES FOR PREDICTING ADULT HEIGHT FROM SKELETAL AGE - REVISED FOR USE WITH THE GREULICH-PYLE HAND STANDARDS [J].
BAYLEY, N ;
PINNEAU, SR .
JOURNAL OF PEDIATRICS, 1952, 40 (04) :423-441
[8]   Evaluation of growth hormone bioactivity using the Nb2 cell bioassay in children with growth disorders [J].
Bozzola, M ;
Zecca, M ;
Locatelli, F ;
Radetti, G ;
Pagani, S ;
Autelli, M ;
Tatò, L ;
Chatelain, P .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1998, 21 (11) :765-770
[9]   PLASMA SOMATOMEDIN ACTIVITY MEASURED AS THYMIDINE FACTOR IN NORMAL-CHILDREN WITH AVERAGE AND CONSTITUTIONALLY TALL STATURE [J].
BOZZOLA, M ;
SCHIMPFF, RM ;
THIERIOTPREVOST, G ;
LEDUC, B ;
JOB, JC .
HORMONE AND METABOLIC RESEARCH, 1982, 14 (07) :372-375
[10]   VARIABILITY IN THE QUANTITATION OF CIRCULATING GROWTH-HORMONE USING COMMERCIAL IMMUNOASSAYS [J].
CELNIKER, AC ;
CHEN, AB ;
WERT, RM ;
SHERMAN, BM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (02) :469-476